 |
市場調査レポート
商品コード
950907
医薬品：世界の業界年間 (2015-2024年)Pharmaceuticals Global Industry Almanac 2015-2024 |
||||||
| 医薬品：世界の業界年間 (2015-2024年) |
|
出版日: 2020年06月30日
発行: MarketLine
ページ情報: 英文 552 Pages
納期: 即納可能
 |
世界の医薬品業界における総収益は、2019年に1兆575億1310万米ドルとなり、2015年から2019年にかけては3.6％のCAGRを示しました。米国、中国、日本は、ドイツ、フランス、スペイン、イタリアなどの欧州の大規模市場と並んで、世界最大の医薬品市場の1つです。
当レポートでは、世界の医薬品業界について調査し、業界の規模 (実績値・予測値) を含む定性的・定量的な情報、主要地域・国別の分析、および主要企業のプロファイルなどを提供しています。
Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
Any currency conversions used in the production of this report have been calculated at constant 2019 annual average exchange rates.
Figures presented in this report are calculated applying the "middle path" scenario - this is based on the current situation in countries where the epidemic burst first, like China as a model countries and the announcements made by governments, stating that the abnormal situation may last up to six months.
The assumption has been made that after this time the economy will gradually go back to the levels recorded before the pandemics by the end of the year. It is also assumed that there is no widespread economic crisis as seen back in 2008 due to announced pay-outs across countries.
At the moment of preparation of this report in April 2020 the economic implications of the lock downs of many economics are still very difficult to predict as there is no indication how long the pandemics could last, the number of sectors forced to stay closed and the scale of the governmental' aid involved. At the same time the weight of the pandemic seriousness is applied on the individual countries in this report based on death to population ratio recorded in countries.
Majority of the industries will see the decline in volume of the goods and services offered by companies. Usually the lower demand would cause the decrease the prices level. However, amid many governments' ordered for many industries to lock down and so the supply chain is distorted that in great pictures mitigate the results of lower demand.
Applied scenarios differ depending on the individual sector, however generally sectors which involves intensive manual labor and face to face interaction seem to be hit the most by present situation. On the other hand the internet based businesses as well as the producers of the vital, subsisted products and services seems to take advantages of the current events.
The global pharmaceuticals market had total revenues of $1,057,513.1m in 2019, representing a compound annual growth rate (CAGR) of 3.6% between 2015 and 2019.
The United States, China, and Japan are some of the largest pharmaceutical markets globally, alongside large European markets such as Germany, France, Spain, and Italy.
Historically, China is producing some of the strongest growth every year, whilst the European markets have been stifled due to current healthcare spending cultures in the region.
比較リスト
